Latest filing published 19 Jul 2019 for Teladoc Health, Inc..
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Peter A. Mcclennen across 2 companies, led by Teladoc Health, Inc. and AMICAS, Inc. The record holds 38 filings, for trades running from 11 August 2006 to 17 July 2019.
The open-market side counts 1 purchase for €4,149 alongside 19 sales for €16.2M. On balance, insiders were net sellers of €16.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 16 option exercises. So far in 2019, the count stands at no purchases and 11 sales.
Most recently, on 19 July 2019, the filings show an open-market sale worth €867k in Teladoc Health, Inc. The last insider purchase was made public on 14 August 2006, 7,376 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 38 declarations